🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07276295
Recruiting Not applicable

Synthetic Versus Autologous Sling For Stress Incontinence

NCT07276295 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-01-12
Last updated
2026-01-16

Condition(s) studied

Urinary Incontinence

Investigational drug(s) / intervention(s)

autologous fascia slingtension-free vaginal tape

autologous fascia sling: Participants will receive autologous fascia sling as surgery for stress predominant urinary incontinence.

tension-free vaginal tape: Participants will receive tension-free vaginal tape as surgery for stress predominant urinary incontinence.

Study summary

This is a multi-centre randomized controlled trial comparing mid-urethral synthetic mesh sling or tension-free vaginal tape (TVT) and autologous fascia sling (AFS) in elderly patients with stress predominant urinary incontinence. The investigators aim to investigate new onset pelvic pain 6 months post-op and objective urinary incontinence cure rate 5 years post-op. Secondary objectives include investigation of opioid use, mental health, sexual health, and other post-op outcomes.

Eligibility

Sex
FEMALE
Min age
60 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult females at birth (female anatomy, any gender) * Greater than or equal to 60 years old * Have stress predominant urinary incontinence (spUI) eligible for both types of surgery (tension-free vaginal tape and autologous fascia sling) * Exhausted conservative management options for UI (Kegel's exercises, physiotherapy, pessary) * Completed childbearing * Able to follow up with clinic visits for up to five years after surgery Exclusion Criteria: * Clinical Frailty Score of 6 or more, as moderate frailty is likely associated with excessive postoperative deterioration * Concurrent pelvic surgery * Neurogenic bladder * Previous UI surgery * Previous pelvic radiation * Previous mesh exposure * Presence of pelvic pain for more than three months in the last five years * Likely unable to follow up * Immunocompromised individuals receiving immunosuppressive medications for at least 3 months * Chronic systemic steroid use for at least 3 months for autoimmune diseases * Unable to stop smoking for at least 3 months prior to surgery and at high risk of restart smoking post-operatively

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
St. Paul's Hospital Vancouver British Columbia Recruiting

More University of British Columbia trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07276295 on ClinicalTrials.gov ↗ ← All trials in Canada